FDA Lets AveXis Know the Information It Needs to Possibly Approve AVXS-101 for SMA Type 1
News
The U.S. Food and Drug Administration has given AveXis a list of information it needs to consider approving AVXS-101 as a treatment for spinal muscular atrophy Type 1. Company officials met with ... Read more